Impurities in pharmaceutical end products

Impurities in pharmaceuticals are the unwanted chemicals that remain with the active pharmaceutical ingredients (APIs), develop during formulation, or during the aging of both API and formulated APIs in medicines. The presence of these unwanted chemicals even in very low concentrations may influence the efficacy and safety of the pharmaceutical products (e.g. genotoxic compounds). Through impurity profiling, you can determine the identity as well as the quantity of low concentrations of impurities in pharmaceuticals. This is an important tool to help you achieve the most efficient possible pharmaceutical products. We use a set of proven strategies and up-to-date equipment to profile the impurities of pharmaceutical products.